BRILUMIN
associated with 60 other trademarks
Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharm...

Words that describe this trademark:

central nervous system  nervous system  treatment disorders  diseases affecting  pharmaceutical preparation  disorders diseases  prevention treatment  preparation  substances  affecting 

Serial Number:

79115766

Mark:

BRILUMIN

Status:

Status Date:

03-26-2022

Filing Date:

Registration Number:

4287411

Registration Date:

02-12-2013

Goods and Services:

Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-27-2012

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

WHITE & CASE LLP

Correspondent Name:

Recent Trademark filings by this company